Company intelligence / Profile preview

Neurokinex

Hemel Hempstead, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Neurokinex delivers established, community-based rehabilitation for neurological impairments, deploying evidence-based, activity-based therapy protocols (including unique protocols as an international NeuroRecovery Network Affiliate). Its programs are established in the UK and serve hundreds of clients annually, but it is not a drug or clinical-stage biotech company.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Non-Academic Healthcare

Partnerships

Christopher & Dana Reeve FoundationNeuroRecovery NetworkSpinal Injuries AssociationSpinal Research

Beyond the preview

Go deeper on Neurokinex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurokinex.

Explore the full profile